• Trichomonas vaginalis, Molecular
  • Neurofibromatosis Type 1 (NF1) Gene Mutation Analysis
  • BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
  • Lysergic Acid Diethylamide, Urine
  • ToRCH Panel, IgG
  • Complement Component C3, Nephritic Factor
  • Immunoglobulin M (IgM), Serum
  • X-Linked Adrenoleukodystrophy (ABCD1) Gene Mutation Analysis, Tissue
  • Zopiclone, Urine
  • 17-Hydroxypregnenolone, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MSK-IMPACT™, Solid Organ Gene Cancer Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MSK-IMPACT™, Solid Organ Gene Cancer Panel
Medical Test

Additional Testing
Access to MSK-IMPACT™, Solid Organ Gene Cancer Panel is restricted.